公司資料
ClearPoint Neuro 股價、新聞與催化劑
- 股票代碼:
- CLPT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
15.50 USD (+1.04%)
收盤價
最後更新: 2026年8月17日
371M USD
市值
股價為何變動
As of Aug 17, 2026, CLPT closed up 1.04% at $15.50. No new same-company headline was identified in the current news window.
公司概覽
Brain and Spine Navigation Company
ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine.
ClearPoint Navigation
The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics.
Cell and Gene Therapy Enablement
ClearPoint works with biopharmaceutical partners on preclinical and clinical delivery of cell and gene therapies directly into the central nervous system.
Neurocritical Care Expansion
The acquisition of IRRAS added the IRRAflow active fluid-exchange system, extending the portfolio into management of intracranial bleeding and neurocritical care.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。